VEGFA and neoplasm: Notably, moxibustion combined with paclitaxel inhibited tumor angiogenesis by downregulating CD34, hypoxia-inducible factor-1α, and VEGFA and counteracted the immunosuppressive microenvironment by inhibiting the interactions between programmed death-1 (PD-1) and its ligand PD-L1.